IBAB Ion Beam Applications SA

IBA – TRANSPARENCY NOTIFICATION

IBA – TRANSPARENCY NOTIFICATION



(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)

Louvain-la-Neuve, Belgium, January 21, 2026 06:00 PM

Summary of the notification

IBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on January 13, 2026.

In its notification, Vallgesa Limited indicated that following an acquisition or disposal of securities or voting rights, Vallcara Limited, a controlled undertaking of Vallgesa Limited, exceeded the 5% threshold on 28/11/2025.

Content of the notification

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights
  • Notification by: A parent undertaking or a controlling person
  • Persons subject to the notification requirement:
NameAddress (for legal entities)
Vallcara Limited (owned 100% by Vallgesa Limited)T6-F09 Tigne Point Sliema TP01, Malta
Vallgesa LimitedT6-F09 Tigne Point Sliema TP01, Malta
  • Date on which the threshold is crossed: 11-28-2025
  • Threshold crossed (in %) : 5%
  • Denominator : 40.514.619
  • Notified details: (extract of the received notification form)
A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked

to the securities
Linked to securitiesNot linked to the securities
Vallgesa Limited0000,00%0,00%
Vallcara Limited 100% owned by



Vallgesa Limited
1,621,5652,040,54105.04%0,00%
Subtotal1,621,5652,040,54105.04%0,00%
TOTAL2,040,54105.04%0,00%



B) Equivalent financial instrumentsAfter the transaction
Holders of equivalent financial instrumentsType of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
       
TOTAL00.00% 



 



TOTAL (A & B)
 



# of voting rights
 



% of voting rights
 2,040,5415.04%
  • Full chain of controlled undertakings through which the holding is effectively held

Vallcara Limited is 100% held by Vallgesa Limited. Vallgesa Limited is not a controlled entity.

  • Additional information

Vallcara Limited has reached the 5% notification threshold due to acquisition of shares.



About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered to be one of the most advanced forms of radiation therapy available today, industrial sterilization, radiopharmaceuticals, and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at:

For further information, please contact:

Elena De Landy

Paralegal: Corporate Affairs and Insurance 

Attachment



EN
21/01/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE

IBA – TRANSPARENCY NOTIFICATION

IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 21, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on January 13, 2026. In its notification, Vallgesa Limited indicated that following an acquisition or d...

 PRESS RELEASE

IBA SA – NOTIFICATION TRANSPARENCE

IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 21 janvier 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le leader mondial des technologies d’accélération de particules, annonce devoir effectuer une notification en matière de transparence conformément à l'article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes (« loi transparence »), à la suite d’une notification reçue le 13 janvier 2026. Dans s...

Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Lewi
 PRESS RELEASE

IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE ...

IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems Louvain-La-Neuve, Belgium, January 19, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announced that it has signed a contract with the University of Texas MD Anderson Cancer Center, ranked #1 in cancer care by U.S. News & World Report, to re-equip and modernize its existing Proton Therapy Center in Houston with three state-of-the-art Proteus®ONE1 systems. IBA was awarded th...

 PRESS RELEASE

IBA choisie par le MD Anderson Cancer Center pour fournir trois systèm...

IBA choisie par le MD Anderson Cancer Center pour fournir trois systèmes Proteus®ONE Louvain-la-Neuve, Belgique, le 19 janvier 2026 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le traitement du cancer, annonce aujourd'hui avoir signé un contrat avec le MD Anderson Cancer Center de l'université du Texas, classé n°1 dans le domaine des soins oncologiques par le U.S. News & World Report, afin de rééquiper et moderniser son centre de protonthérapie d’Houston avec trois sy...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch